CNE100003NX4
CNE100003NX4
SHANGHAI HAOHAI BIOLOGICAL TECH
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 6.89B EUR | 6.5B EUR | 8.9B EUR |
Enterprise Value | 5.12B EUR | 4.62B EUR | 8.9B EUR |
Valuation Multiples | |||
Trailing P/E | 46.62x | -- | -- |
Forward P/E | 12.41x | -- | -- |
Price to Sales | 2.97x | -- | -- |
Price to Book | 1.3x | 1.22x | -- |
EV/Revenue | 2.21x | -- | -- |
EV/EBITDA | 16.5x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -1.51% | -- | -- |